Used as an intermediate in the synthesis of biologically active compounds, particularly in pharmaceutical development. Its structure supports the creation of protease inhibitors and other drug candidates targeting viral infections and central nervous system disorders. The fluorinated pyrrolidine ring enhances metabolic stability and membrane permeability, making it valuable in optimizing pharmacokinetic properties. Commonly employed in medicinal chemistry for structure-activity relationship studies.